Obdeijn, I., Mann, R. M., Loo, C. C. E., Lobbes, M., Voormolen, E. M. C., van Deurzen, C. H. M., . . . Hooning, M. J. (2020). The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers. Breast Cancer Res Treat.
Style de citation ChicagoObdeijn, Inge-Marie, Ritse M. Mann, Claudette C. E. Loo, Marc Lobbes, Eleonora M. C. Voormolen, Carolien H. M. van Deurzen, Geertruida de Bock, et Maartje J. Hooning. "The Supplemental Value of Mammographic Screening Over Breast MRI Alone in BRCA2 Mutation Carriers." Breast Cancer Res Treat 2020.
Style de citation MLAObdeijn, Inge-Marie, et al. "The Supplemental Value of Mammographic Screening Over Breast MRI Alone in BRCA2 Mutation Carriers." Breast Cancer Res Treat 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.